European Patent Office

T 0745/23 (preventing bacterial infection in fermentation/KEMIRA) du 20.03.2025

Identifiant européen de la jurisprudence
ECLI:EP:BA:2025:T074523.20250320
Date de la décision
20 mars 2025
Numéro de l'affaire
T 0745/23
Requête en révision de
-
Numéro de la demande
11859141.1
Langue de la procédure
Anglais
Distribution
Distribuées aux présidents des chambres de recours (C)
Téléchargement
Décision en anglais
Versions JO
Aucun lien JO trouvé
Autres décisions pour cet affaire
-
Résumés pour cette décision
Résumé de Article 15a RPBA
Titre de la demande
Method for preventing bacterial infection in a fermentation process
Nom du demandeur
Kemira OYJ
Nom de l'opposant
ECOLAB USA INC.
Chambre
3.3.08
Sommaire
-
Dispositions juridiques pertinentes
European Patent Convention Art 112(1)European Patent Convention Art 123(2)Rules of procedure of the Boards of Appeal 2020 Art 013(2)Rules of procedure of the Boards of Appeal 2020 Art 021Rules of procedure of the Boards of Appeal 2020 Art 15a(1)
Mots-clés
Oral proceedings by videoconference
Referral to the Enlarged Board of Appeal - (no)
Amendments - allowable (no)
New request filed at oral proceedings - admitted (no)
Exergue
Article 15a RPBA provides the board with the discretion to decide to hold oral proceedings pursuant to Article 116 EPC by videoconference if the board considers it appropriate to do so, either upon a party's request or of its own motion. Its scope is general and not limited to a pandemic situation (see point 7 of the Reasons).
The board exercises its discretion in view of the particular circumstances of the case and of the reasons provided by each party in support of their opposing requests as to the format, including the reasons why the party not consenting to a videoconference considers that videoconference, in the case in hand, is not suitable or why the party is otherwise disadvantaged (see points 10-13 of the Reasons).
Affaires citantes
-

Order

For these reasons it is decided that:

1. The request for referral of questions to the Enlarged Board of Appeal is rejected.

2. The decision under appeal is set aside.

3. The patent is revoked.